- Home
- BQ vs CMND Comparison
BQ vs CMND Comparison
Compare BQ & CMND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | BQ | CMND |
|---|---|---|
| Founded | 2008 | 2017 |
| Country | China | Canada |
| Employees | N/A | N/A |
| Industry | Other Specialty Stores | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.2M | 2.6M |
| IPO Year | 2020 | 2021 |
Fundamental Metrics
Financial Performance| Metric | BQ | CMND |
|---|---|---|
| Price | $0.93 | $2.98 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 1.2M | ★ 2.5M |
| Earning Date | 01-05-2026 | 03-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.65 | $0.07 |
| 52 Week High | $72.74 | $4.66 |
Technical Indicators
Market Signals| Indicator | BQ | CMND |
|---|---|---|
| Relative Strength Index (RSI) | 50.68 | 56.83 |
| Support Level | $0.69 | $0.31 |
| Resistance Level | $0.96 | $3.25 |
| Average True Range (ATR) | 0.17 | 0.44 |
| MACD | 0.01 | -0.10 |
| Stochastic Oscillator | 30.81 | 11.67 |
Price Performance
Historical ComparisonAbout BQ Boqii Holding Limited representing
Boqii Holding Ltd operates in the business of selling pet products through online stores. The store provides pet foods, health products, pet grooming products, pet bathing products, pet toys, fish tank, aquatic fertilizer, temperature control equipment, oxygen pump and other related products. Also, the company sells its products through offline channels to pet stores and hospitals.
About CMND Clearmind Medicine Inc.
Clearmind Medicine Inc is a clinical-stage pharmaceutical company engaged in Phase I/IIa clinical trials of novel psychedelic medicines. The Company focuses on developing treatments for mental health disorders, including alcohol use disorder (AUD), binge drinking, and eating disorders. Its activities are centered on the research and development of 5-methoxy-2-aminoindane (MEAI). It operates through a single research and development segment, which is conducted in Israel.